Have you recently been downsized from a large medtech, biotech, or pharma company? If so, perhaps it’s time to change your paradigm. That’s what Paula Norbom thinks. She is the Founder and President of Talencio, a Minneapolis-based staffing company that places contract professionals in various roles within the medtech and and biotech industries.
Paula is a senior executive with over 24 years of broad operational and financial management experience. Before founding Talencio, Paula served as the VP Operations and Finance for ThreeWire Inc., a clinical trial patient recruitment firm. Prior to ThreeWire, Paula played a key roll in successful liquidity events at three distinct medical device companies: Restore Medical (acquired by Medtronic), Spine-Tech, and IntraTherapeutics. Paula served as Vice President Finance and Treasurer for Restore Medical, Inc., an emerging growth medical device company. She also served as Vice President Controller for two Centerpulse-owned medical device companies: Spine-Tech and IntraTherapeutics.
Paula began her career as an independent auditor with Ernst and Young in Milwaukee, WI. She completed her undergraduate studies at the University of Wisconsin, La Crosse and is a certified public accountant.
With the Rise of AI, What IP Disputes in Healthcare Are Likely to Emerge?
Munck Wilson Mandala Partner Greg Howison shared his perspective on some of the legal ramifications around AI, IP, connected devices and the data they generate, in response to emailed questions.
IN THIS INTERVIEW, WE DISCUSS:
- The role of contract services in the med-tech, lifescience, and healthcare arenas.
- Why Paula believes networking is so important. Clue: the wake-up call may come sooner than you think!
- 3 hot and in-demand areas that medical device, lifescience, and healthcare companies are looking for.
- How you can retool if you’ve been laid off from a healthcare company.
- Why you must know your 3 most marketable skills.
- And much, much more!
LISTEN TO THE INTERVIEW:
Laid Off from a Large Medical Device Company? Get a Clue and Retool!
A Deep-dive Into Specialty Pharma
A specialty drug is a class of prescription medications used to treat complex, chronic or rare medical conditions. Although this classification was originally intended to define the treatment of rare, also termed “orphan” diseases, affecting fewer than 200,000 people in the US, more recently, specialty drugs have emerged as the cornerstone of treatment for chronic and complex diseases such as cancer, autoimmune conditions, diabetes, hepatitis C, and HIV/AIDS.
CONNECT WITH PAULA:
Paula Norbom is the Founder and President of Talencio, a Minneapolis-based staffing company that that places contract professionals in various roles within the medtech and biotech industries. If you enjoyed this interview, tell Paula via LinkedIn.
This post appears through the MedCity Influencers program. Anyone can publish their perspective on business and innovation in healthcare on MedCity News through MedCity Influencers. Click here to find out how.
